世界の抗菌ペプチド販売市場2021

QYResearchが発行した調査報告書(QYR21JN7569)
◆英語タイトル:Global Antimicrobial Peptides Sales Market Report 2021
◆商品コード:QYR21JN7569
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月20日(※2024年版があります。お問い合わせください。)
◆ページ数:148
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の抗菌ペプチド市場について種類別(植物抗菌ペプチド、微生物抗菌ペプチド、動物抗菌ペプチド)、用途別(医薬品、飼料添加物、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・抗菌ペプチド市場の概要
・世界の主要地域別抗菌ペプチド市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の抗菌ペプチド市場規模2016-2021:種類別(植物抗菌ペプチド、微生物抗菌ペプチド、動物抗菌ペプチド)
・世界の抗菌ペプチド市場予測2012-2027:種類別(植物抗菌ペプチド、微生物抗菌ペプチド、動物抗菌ペプチド)
・世界の抗菌ペプチド市場規模2016-2021:用途別(医薬品、飼料添加物、その他)
・世界の抗菌ペプチド市場予測2012-2027:用途別(医薬品、飼料添加物、その他)
・抗菌ペプチドのアメリカ市場規模と予測2016-2021
・抗菌ペプチドのヨーロッパ市場規模と予測2016-2021
・抗菌ペプチドの中国市場規模と予測2016-2021
・抗菌ペプチドの日本市場規模と予測2016-2021
・抗菌ペプチドの東南アジア市場規模と予測2016-2021
・抗菌ペプチドのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(AnaSpec、AMP Biotech、Phoenix Biotech、Novabiotics、Chinese Peptide、Ontores、GenScript、Hycult Biotech、Sunsmile、Ruixing Biotechnology、Zhongnong Yingtai Biotechnology、Glam Technology、ProteLight Pharmaceutical & Biotechnology)
・抗菌ペプチドの製造コスト分析
・販売チャネル、流通業者、顧客
・抗菌ペプチドの市場動向・機会・課題
・調査の結論
【レポートの概要】

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.

Market Analysis and Insights: Global Antimicrobial Peptides Market
The global Antimicrobial Peptides market was valued at US$ 5 in 2020 and will reach US$ 6 million by the end of 2027, growing at a CAGR of 5.4% during 2022-2027.

Global Antimicrobial Peptides Scope and Market Size
The global Antimicrobial Peptides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antimicrobial Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides

Segment by Application
Pharmaceuticals
Feed Additives
Others

The Antimicrobial Peptides market is analysed and market size information is provided by regions (countries). Segment by Application, the Antimicrobial Peptides market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology

【レポートの目次】

1 Antimicrobial Peptides Market Overview
1.1 Antimicrobial Peptides Product Scope
1.2 Antimicrobial Peptides Segment by Type
1.2.1 Global Antimicrobial Peptides Sales by Type (2016 & 2021 & 2027)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides Segment by Application
1.3.1 Global Antimicrobial Peptides Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Antimicrobial Peptides Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antimicrobial Peptides Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antimicrobial Peptides Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antimicrobial Peptides Price Trends (2016-2027)

2 Antimicrobial Peptides Estimates and Forecasts by Region
2.1 Global Antimicrobial Peptides Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antimicrobial Peptides Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antimicrobial Peptides Sales Market Share by Region (2016-2021)
2.2.2 Global Antimicrobial Peptides Revenue Market Share by Region (2016-2021)
2.3 Global Antimicrobial Peptides Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antimicrobial Peptides Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antimicrobial Peptides Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.2 Europe Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.3 China Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.4 Japan Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.6 India Antimicrobial Peptides Estimates and Projections (2016-2027)
3 Global Antimicrobial Peptides Competition Landscape by Players
3.1 Global Top Antimicrobial Peptides Players by Sales (2016-2021)
3.2 Global Top Antimicrobial Peptides Players by Revenue (2016-2021)
3.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2020)
3.4 Global Antimicrobial Peptides Average Price by Company (2016-2021)
3.5 Manufacturers Antimicrobial Peptides Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antimicrobial Peptides Market Size by Type
4.1 Global Antimicrobial Peptides Historic Market Review by Type (2016-2021)
4.1.1 Global Antimicrobial Peptides Sales Market Share by Type (2016-2021)
4.1.2 Global Antimicrobial Peptides Revenue Market Share by Type (2016-2021)
4.1.3 Global Antimicrobial Peptides Price by Type (2016-2021)
4.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antimicrobial Peptides Sales Forecast by Type (2022-2027)
4.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2022-2027)
4.2.3 Global Antimicrobial Peptides Price Forecast by Type (2022-2027)
5 Global Antimicrobial Peptides Market Size by Application
5.1 Global Antimicrobial Peptides Historic Market Review by Application (2016-2021)
5.1.1 Global Antimicrobial Peptides Sales Market Share by Application (2016-2021)
5.1.2 Global Antimicrobial Peptides Revenue Market Share by Application (2016-2021)
5.1.3 Global Antimicrobial Peptides Price by Application (2016-2021)
5.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antimicrobial Peptides Sales Forecast by Application (2022-2027)
5.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2022-2027)
5.2.3 Global Antimicrobial Peptides Price Forecast by Application (2022-2027)

6 North America Antimicrobial Peptides Market Facts & Figures
6.1 North America Antimicrobial Peptides Sales by Company
6.1.1 North America Antimicrobial Peptides Sales by Company (2016-2021)
6.1.2 North America Antimicrobial Peptides Revenue by Company (2016-2021)
6.2 North America Antimicrobial Peptides Sales Breakdown by Type
6.2.1 North America Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
6.2.2 North America Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
6.3 North America Antimicrobial Peptides Sales Breakdown by Application
6.3.1 North America Antimicrobial Peptides Sales Breakdown by Application (2016-2021)
6.3.2 North America Antimicrobial Peptides Sales Breakdown by Application (2022-2027)

7 Europe Antimicrobial Peptides Market Facts & Figures
7.1 Europe Antimicrobial Peptides Sales by Company
7.1.1 Europe Antimicrobial Peptides Sales by Company (2016-2021)
7.1.2 Europe Antimicrobial Peptides Revenue by Company (2016-2021)
7.2 Europe Antimicrobial Peptides Sales Breakdown by Type
7.2.1 Europe Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
7.3 Europe Antimicrobial Peptides Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Antimicrobial Peptides Market Facts & Figures
8.1 China Antimicrobial Peptides Sales by Company
8.1.1 China Antimicrobial Peptides Sales by Company (2016-2021)
8.1.2 China Antimicrobial Peptides Revenue by Company (2016-2021)
8.2 China Antimicrobial Peptides Sales Breakdown by Type
8.2.1 China Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
8.2.2 China Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
8.3 China Antimicrobial Peptides Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)

9 Japan Antimicrobial Peptides Market Facts & Figures
9.1 Japan Antimicrobial Peptides Sales by Company
9.1.1 Japan Antimicrobial Peptides Sales by Company (2016-2021)
9.1.2 Japan Antimicrobial Peptides Revenue by Company (2016-2021)
9.2 Japan Antimicrobial Peptides Sales Breakdown by Type
9.2.1 Japan Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
9.3 Japan Antimicrobial Peptides Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Antimicrobial Peptides Market Facts & Figures
10.1 Southeast Asia Antimicrobial Peptides Sales by Company
10.1.1 Southeast Asia Antimicrobial Peptides Sales by Company (2016-2021)
10.1.2 Southeast Asia Antimicrobial Peptides Revenue by Company (2016-2021)
10.2 Southeast Asia Antimicrobial Peptides Sales Breakdown by Type
10.2.1 Southeast Asia Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antimicrobial Peptides Sales Breakdown by Application
10.3.1 Southeast Asia Mg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Mg Sales Breakdown by Application (2022-2027)

11 India Antimicrobial Peptides Market Facts & Figures
11.1 India Antimicrobial Peptides Sales by Company
11.1.1 India Antimicrobial Peptides Sales by Company (2016-2021)
11.1.2 India Antimicrobial Peptides Revenue by Company (2016-2021)
11.2 India Antimicrobial Peptides Sales Breakdown by Type
11.2.1 India Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
11.2.2 India Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
11.3 India Antimicrobial Peptides Sales Breakdown by Application
11.3.1 India Antimicrobial Peptides Sales Breakdown by Application (2016-2021)
11.3.2 India Antimicrobial Peptides Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Antimicrobial Peptides Business
12.1 AnaSpec
12.1.1 AnaSpec Corporation Information
12.1.2 AnaSpec Business Overview
12.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AnaSpec Antimicrobial Peptides Products Offered
12.1.5 AnaSpec Recent Development
12.2 AMP Biotech
12.2.1 AMP Biotech Corporation Information
12.2.2 AMP Biotech Business Overview
12.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AMP Biotech Antimicrobial Peptides Products Offered
12.2.5 AMP Biotech Recent Development
12.3 Phoenix Biotech
12.3.1 Phoenix Biotech Corporation Information
12.3.2 Phoenix Biotech Business Overview
12.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
12.3.5 Phoenix Biotech Recent Development
12.4 Novabiotics
12.4.1 Novabiotics Corporation Information
12.4.2 Novabiotics Business Overview
12.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novabiotics Antimicrobial Peptides Products Offered
12.4.5 Novabiotics Recent Development
12.5 Chinese Peptide
12.5.1 Chinese Peptide Corporation Information
12.5.2 Chinese Peptide Business Overview
12.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
12.5.5 Chinese Peptide Recent Development
12.6 Ontores
12.6.1 Ontores Corporation Information
12.6.2 Ontores Business Overview
12.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ontores Antimicrobial Peptides Products Offered
12.6.5 Ontores Recent Development
12.7 GenScript
12.7.1 GenScript Corporation Information
12.7.2 GenScript Business Overview
12.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GenScript Antimicrobial Peptides Products Offered
12.7.5 GenScript Recent Development
12.8 Hycult Biotech
12.8.1 Hycult Biotech Corporation Information
12.8.2 Hycult Biotech Business Overview
12.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
12.8.5 Hycult Biotech Recent Development
12.9 Sunsmile
12.9.1 Sunsmile Corporation Information
12.9.2 Sunsmile Business Overview
12.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sunsmile Antimicrobial Peptides Products Offered
12.9.5 Sunsmile Recent Development
12.10 Ruixing Biotechnology
12.10.1 Ruixing Biotechnology Corporation Information
12.10.2 Ruixing Biotechnology Business Overview
12.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
12.10.5 Ruixing Biotechnology Recent Development
12.11 Zhongnong Yingtai Biotechnology
12.11.1 Zhongnong Yingtai Biotechnology Corporation Information
12.11.2 Zhongnong Yingtai Biotechnology Business Overview
12.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
12.11.5 Zhongnong Yingtai Biotechnology Recent Development
12.12 Glam Technology
12.12.1 Glam Technology Corporation Information
12.12.2 Glam Technology Business Overview
12.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Glam Technology Antimicrobial Peptides Products Offered
12.12.5 Glam Technology Recent Development
12.13 ProteLight Pharmaceutical & Biotechnology
12.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
12.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
12.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
12.13.5 ProteLight Pharmaceutical & Biotechnology Recent Development

13 Antimicrobial Peptides Manufacturing Cost Analysis
13.1 Antimicrobial Peptides Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antimicrobial Peptides
13.4 Antimicrobial Peptides Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antimicrobial Peptides Distributors List
14.3 Antimicrobial Peptides Customers

15 Market Dynamics
15.1 Antimicrobial Peptides Market Trends
15.2 Antimicrobial Peptides Drivers
15.3 Antimicrobial Peptides Market Challenges
15.4 Antimicrobial Peptides Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗菌ペプチド販売市場2021(Global Antimicrobial Peptides Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。